Please provide your email address to receive an email when new articles are posted on . The Alzheimer’s Drug Discovery Foundation has invested $5 million in Coya Therapeutics to help accelerate ...
Add Yahoo as a preferred source to see more of our stories on Google. Jo Carole Lauder and Jane Lauder at the Alzheimer's Drug Discovery Foundation Fifth Annual Hope on the Horizon Event at The Beach ...
A new analysis of the Alzheimer's drug development pipeline, led by Goodes Prize winner and longtime Alzheimer's Drug Discovery Foundation (ADDF) collaborator Dr. Jeff Cummings; Joy Chambers-Grundy ...
NEW YORK, March 17, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced the launch of the third phase of its Diagnostics Accelerator (DxA), backed by an additional ...
"Randy embodies exactly what the Goodes Prize was established to recognize: science that changes the trajectory of the field," said Howard Fillit, MD, Co-Founder and Chief Science Officer of the ADDF.
The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted an ADDF-Harrington Scholar Award to Christiane Wrann, PhD, DVM, ...
San Francisco, CA (November 30, 2022) – The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference demonstrate why optimal ...
As part of its Diagnostics Accelerator research program, the Alzheimer's Drug Discovery Foundation (ADDF) announced today a new initiative that aims to fast-track the development of digital tools for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results